HeartBeam Ranks Second Globally in 12-Lead ECG Innovation, Signaling Progress in Portable Cardiac Monitoring

HeartBeam Inc. has been recognized as the second most innovative company in 12-lead ECG technology worldwide, highlighting its proprietary synthesis-ECG system that enables high-quality cardiac monitoring outside traditional hospital settings.

AI Industry News Staff
Healthcare
HeartBeam Ranks Second Globally in 12-Lead ECG Innovation, Signaling Progress in Portable Cardiac Monitoring

HeartBeam Inc. (NASDAQ: BEAT) has been recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide in 12-lead ECG innovation among 243 firms analyzed, according to PatentVest's "Total Cardiac Intelligence" report. The recognition places HeartBeam behind only GE Healthcare, underscoring the company's rapid progress in the next generation of cardiac monitoring technology.

HeartBeam's ranking reflects the maturation of its proprietary synthesis-ECG system, which captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a standard 12-lead ECG. This approach enables physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings. The company is currently cleared for arrhythmia detection, with ischemia assessment as a future goal.

"HeartBeam's ranking underscores the rapid maturation of the company's proprietary synthesis-ECG system, which captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG," reads the article featuring the company. "This unique approach allows physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings. In doing so, HeartBeam is addressing one of modern medicine's most persistent challenges: delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are."

The company holds 13 U.S. and 4 international-issued patents related to its technology enablement, and its platform technology is designed for portable devices that deliver actionable heart intelligence outside of medical facilities. Physicians can identify cardiac health trends and acute conditions and direct patients to appropriate care, redefining the future of cardiac health management.

For more details, the full article is available at https://ibn.fm/3ADRP. Additional information about HeartBeam can be found at www.HeartBeam.com.

Blockchain Registration

QR Code for Blockchain Registration